The association of vitamin K status with warfarin sensitivity at the onset of treatment.
about
Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiationWarfarin and vitamin K intake in the era of pharmacogenetics.Supplemental vitamin K improves the stability of anticoagulation in a patient with low tissue stores of vitamin K secondary to coeliac diseaseVitamin K1 supplementation to improve the stability of anticoagulation therapy with vitamin K antagonists: a dose-finding study.Interaction of warfarin with drugs, natural substances, and foods.The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans.Patient factors that influence warfarin dose response.Current challenges in personalizing warfarin therapy.Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True?: A Systematic Review.Patient-specific factors predictive of warfarin dosage requirements.Multivitamin supplements may affect warfarin anticoagulation in susceptible patients.Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium.Finding the optimal dose of vitamin K1 to treat vitamin K deficiency and to avoid anaphylactoid reactions.High intra- and inter-individual variability of plasma vitamin K concentrations in patients with atrial fibrillation under warfarin therapy.Effect of the VKORC1 D36Y variant on warfarin dose requirement and pharmacogenetic dose prediction.Establishing a rat model for the study of vitamin K deficiency.
P2860
Q31042226-72FAF82D-E767-4BBA-A893-F6B969B05030Q34026225-9A2420A6-ADD6-4103-B096-1851129DD058Q34630398-81192BAE-0BBD-41D5-A78C-5B9B0154379BQ34750575-98D11A4F-6321-4506-9393-01A408B39C14Q36007599-F7279849-F0B6-4D83-9E45-FFE38AA07280Q36762797-4BBB6D1E-185D-4005-ADE6-FE604D932887Q37867275-68579EA8-AB7E-4BDA-B396-31496925E744Q37960511-91CAB225-FD24-4057-9370-E6A4D021E875Q38768207-EFA7F694-7281-4DF5-B17A-2B6D99AAB931Q44146616-C6A620CE-24A1-4174-A727-605BCD31EDB0Q44622773-E70272E6-DE41-4B4F-B473-A96CD13009D9Q46607001-1691BAA5-D011-4997-A211-5BFB50D045FEQ48277190-8BE666D5-0ABA-409B-84B7-7EFB5B91B737Q49124249-1DD1455F-BB27-41F0-A47F-3875902EA46DQ51335958-432FA440-9F62-4BCF-97A1-B6C23301F708Q51723075-7A65564F-4663-489E-9327-613326BBD2D0
P2860
The association of vitamin K status with warfarin sensitivity at the onset of treatment.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
The association of vitamin K status with warfarin sensitivity at the onset of treatment.
@en
The association of vitamin K status with warfarin sensitivity at the onset of treatment.
@nl
type
label
The association of vitamin K status with warfarin sensitivity at the onset of treatment.
@en
The association of vitamin K status with warfarin sensitivity at the onset of treatment.
@nl
prefLabel
The association of vitamin K status with warfarin sensitivity at the onset of treatment.
@en
The association of vitamin K status with warfarin sensitivity at the onset of treatment.
@nl
P2093
P2860
P1476
The association of vitamin K status with warfarin sensitivity at the onset of treatment.
@en
P2093
Davidson KW
Possidente CJ
Sadowski JA
P2860
P304
P356
10.1046/J.1365-2141.2001.02635.X
P407
P577
2001-03-01T00:00:00Z